JP2008540366A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008540366A5 JP2008540366A5 JP2008509408A JP2008509408A JP2008540366A5 JP 2008540366 A5 JP2008540366 A5 JP 2008540366A5 JP 2008509408 A JP2008509408 A JP 2008509408A JP 2008509408 A JP2008509408 A JP 2008509408A JP 2008540366 A5 JP2008540366 A5 JP 2008540366A5
- Authority
- JP
- Japan
- Prior art keywords
- tiotropium bromide
- solvate
- crystalline
- dried
- crystalline tiotropium
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 229960000257 tiotropium bromide Drugs 0.000 claims 43
- LERNTVKEWCAPOY-VOGVJGKGSA-N C[N+]1(C)[C@H]2C[C@H](C[C@@H]1[C@H]1O[C@@H]21)OC(=O)C(O)(c1cccs1)c1cccs1 Chemical compound C[N+]1(C)[C@H]2C[C@H](C[C@@H]1[C@H]1O[C@@H]21)OC(=O)C(O)(c1cccs1)c1cccs1 LERNTVKEWCAPOY-VOGVJGKGSA-N 0.000 claims 41
- 239000012453 solvate Substances 0.000 claims 40
- 239000002904 solvent Substances 0.000 claims 27
- OKKJLVBELUTLKV-UHFFFAOYSA-N methanol Substances OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims 21
- 239000013078 crystal Substances 0.000 claims 17
- MQLXPRBEAHBZTK-SEINRUQRSA-M tiotropium bromide hydrate Chemical compound O.[Br-].C[N+]1(C)[C@H]2C[C@@H](C[C@@H]1[C@H]1O[C@@H]21)OC(=O)C(O)(c1cccs1)c1cccs1 MQLXPRBEAHBZTK-SEINRUQRSA-M 0.000 claims 16
- 238000004519 manufacturing process Methods 0.000 claims 13
- WYURNTSHIVDZCO-UHFFFAOYSA-N tetrahydrofuran Substances C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims 11
- 238000010586 diagram Methods 0.000 claims 10
- 239000000843 powder Substances 0.000 claims 10
- 238000001816 cooling Methods 0.000 claims 9
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-dimethylformamide Substances CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims 8
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N EtOH Substances CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims 7
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims 6
- JUJWROOIHBZHMG-UHFFFAOYSA-N pyridine Substances C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims 6
- LRHPLDYGYMQRHN-UHFFFAOYSA-N Butanol Natural products CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 claims 5
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 claims 5
- KFZMGEQAYNKOFK-UHFFFAOYSA-N isopropyl alcohol Natural products CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims 5
- RDOXTESZEPMUJZ-UHFFFAOYSA-N methyl phenyl ether Natural products COC1=CC=CC=C1 RDOXTESZEPMUJZ-UHFFFAOYSA-N 0.000 claims 5
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 claims 4
- 238000001035 drying Methods 0.000 claims 4
- UZKWTJUDCOPSNM-UHFFFAOYSA-N methoxybenzene Substances CCCCOC=C UZKWTJUDCOPSNM-UHFFFAOYSA-N 0.000 claims 4
- 239000008194 pharmaceutical composition Substances 0.000 claims 4
- 238000012916 structural analysis Methods 0.000 claims 4
- 229940110309 tiotropium Drugs 0.000 claims 4
- LERNTVKEWCAPOY-DZZGSBJMSA-N tiotropium Chemical compound O([C@H]1C[C@@H]2[N+]([C@H](C1)[C@@H]1[C@H]2O1)(C)C)C(=O)C(O)(C=1SC=CC=1)C1=CC=CS1 LERNTVKEWCAPOY-DZZGSBJMSA-N 0.000 claims 4
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 claims 3
- DHXVGJBLRPWPCS-UHFFFAOYSA-N Tetrahydropyran Chemical compound C1CCOCC1 DHXVGJBLRPWPCS-UHFFFAOYSA-N 0.000 claims 3
- 238000000034 method Methods 0.000 claims 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N monopropylene glycol Natural products CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims 3
- 235000013772 propylene glycol Nutrition 0.000 claims 3
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 claims 3
- 239000007787 solid Substances 0.000 claims 3
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical compound C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 claims 2
- 239000000808 adrenergic beta-agonist Substances 0.000 claims 2
- 230000003454 betamimetic effect Effects 0.000 claims 2
- 239000007788 liquid Substances 0.000 claims 2
- -1 tiotropium bromide anhydride Chemical class 0.000 claims 2
- 239000004480 active ingredient Substances 0.000 claims 1
- 150000008064 anhydrides Chemical class 0.000 claims 1
- 239000005557 antagonist Substances 0.000 claims 1
- 208000006673 asthma Diseases 0.000 claims 1
- 229940121647 egfr inhibitor Drugs 0.000 claims 1
- 239000003112 inhibitor Substances 0.000 claims 1
- YEESKJGWJFYOOK-IJHYULJSSA-N leukotriene D4 Chemical compound CCCCC\C=C/C\C=C/C=C/C=C/[C@H]([C@@H](O)CCCC(O)=O)SC[C@H](N)C(=O)NCC(O)=O YEESKJGWJFYOOK-IJHYULJSSA-N 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 238000002360 preparation method Methods 0.000 claims 1
- 208000023504 respiratory system disease Diseases 0.000 claims 1
- 239000011877 solvent mixture Substances 0.000 claims 1
- 239000007858 starting material Substances 0.000 claims 1
- 150000003431 steroids Chemical group 0.000 claims 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US67680705P | 2005-05-02 | 2005-05-02 | |
| US60/676,807 | 2005-05-02 | ||
| PCT/EP2006/061763 WO2006117299A2 (en) | 2005-05-02 | 2006-04-21 | Novel crystalline forms of tiotropium bromide |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2008540366A JP2008540366A (ja) | 2008-11-20 |
| JP2008540366A5 true JP2008540366A5 (https=) | 2009-06-18 |
| JP5227790B2 JP5227790B2 (ja) | 2013-07-03 |
Family
ID=36693210
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008509408A Expired - Lifetime JP5227790B2 (ja) | 2005-05-02 | 2006-04-21 | 新規結晶性臭化チオトロピウム |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US7879871B2 (https=) |
| EP (2) | EP2085396A3 (https=) |
| JP (1) | JP5227790B2 (https=) |
| KR (1) | KR20080012932A (https=) |
| CN (1) | CN101166738B (https=) |
| AR (1) | AR053599A1 (https=) |
| AU (1) | AU2006243238B2 (https=) |
| BR (1) | BRPI0609295A2 (https=) |
| CA (1) | CA2606549A1 (https=) |
| DK (1) | DK1881980T3 (https=) |
| ES (1) | ES2393794T3 (https=) |
| IL (1) | IL187055A (https=) |
| MX (1) | MX2007013142A (https=) |
| NZ (1) | NZ563596A (https=) |
| PE (1) | PE20061438A1 (https=) |
| PL (1) | PL1881980T3 (https=) |
| PT (1) | PT1881980E (https=) |
| RU (1) | RU2417224C2 (https=) |
| SI (1) | SI1881980T1 (https=) |
| TW (1) | TWI392674B (https=) |
| UY (1) | UY29506A1 (https=) |
| WO (1) | WO2006117299A2 (https=) |
| ZA (1) | ZA200708048B (https=) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RS52663B2 (sr) * | 2005-12-19 | 2018-05-31 | Sicor Inc | Nova kristalna forma tiotropijum bromida i proces njene pripreme |
| EP1966196A2 (en) * | 2005-12-19 | 2008-09-10 | Sicor, Inc. | Pure and stable tiotropium bromide |
| US9108962B2 (en) | 2005-12-19 | 2015-08-18 | Sicor, Inc. | Forms of tiotropium bromide and processes for preparation thereof |
| CN100999521B (zh) * | 2006-01-13 | 2010-12-08 | 江苏正大天晴药业股份有限公司 | 结晶性抗胆碱药噻托溴铵 |
| US20080051582A1 (en) | 2006-07-10 | 2008-02-28 | Sicor Inc. | Process for the preparation of tiotropium bromide |
| EP1923393A1 (en) * | 2006-11-17 | 2008-05-21 | Boehringer Ingelheim Pharma GmbH & Co. KG | Crystalline form of tiotropium bromide and urea |
| GB0716026D0 (en) * | 2007-08-16 | 2007-09-26 | Norton Healthcare Ltd | An inhalable medicament |
| DK2240477T3 (en) * | 2008-01-10 | 2014-12-08 | Generics Uk Ltd | New process for the preparation of skopinestre |
| JP2012507574A (ja) * | 2008-11-04 | 2012-03-29 | シプラ・リミテッド | 医薬エアロゾル組成物 |
| WO2010052450A1 (en) * | 2008-11-04 | 2010-05-14 | Cipla Limited | Tiotropium bromide having a low degree of crystallinity |
| EP2403851B1 (en) | 2009-03-06 | 2015-06-17 | Mahmut Bilgic | New crystalline forms of tiotropium bromide |
| WO2011015883A1 (en) | 2009-08-07 | 2011-02-10 | Generics [Uk] Limited | Dichloromethane solvate of tiotropium bromide and its use |
| NZ597920A (en) | 2009-08-07 | 2014-05-30 | Generics Uk Ltd | Anhydrate of tiotropium bromide |
| TR201007108A2 (tr) * | 2010-08-25 | 2012-03-21 | B�Lg�� Mahmut | Yeni tiotropyum bromür kristali ve üretim yöntemi.@ |
| TR201111589A2 (tr) * | 2011-03-03 | 2012-09-21 | Bi̇lgi̇ç Mahmut | Tiotropyum bromür susuz kristal formu. |
| TR201102068A2 (tr) | 2011-03-03 | 2012-09-21 | Bi̇lgi̇ç Mahmut | Tiotropyum bromür içeren kristal maddeler |
| CZ304368B6 (cs) * | 2011-11-28 | 2014-04-02 | Zentiva, K.S. | Směsný solvát tiotropium bromidu a způsob jeho přípravy |
| GB201200525D0 (en) | 2011-12-19 | 2012-02-29 | Teva Branded Pharmaceutical Prod R & D Inc | An inhalable medicament |
| PT106142B (pt) | 2012-02-10 | 2014-07-18 | Hovione Farmaci Ncia S A | Processo para a preparação de brometo de tiotrópio |
| EP2897955B1 (en) * | 2012-09-11 | 2019-11-06 | Bilgic, Mahmut | New tiotropium bromide crystalline form |
| UA115888C2 (uk) * | 2012-11-05 | 2018-01-10 | Зентіва, К.С. | Стабілізація сольватів тіотропію |
| JP6473738B2 (ja) | 2013-04-01 | 2019-02-20 | パルマトリックス，インコーポレイテッド | チオトロピウム乾燥粉末 |
| EP2913332A1 (en) | 2014-02-27 | 2015-09-02 | Euticals S.P.A. | Crystalline form of tiotropium bromide with lactose |
| US10034866B2 (en) | 2014-06-19 | 2018-07-31 | Teva Branded Pharmaceutical Products R&D, Inc. | Inhalable medicament comprising tiotropium |
| WO2017138896A1 (en) * | 2016-02-11 | 2017-08-17 | Sima Patent Ve Lisanslama Hizmetleri Ltd. Şti | Crystalline form of tiotropium bromide anhydrate |
| PT115583B (pt) | 2019-06-17 | 2022-05-02 | Hovione Farm S A | Processo contínuo para a preparação de medicamentos anticolinérgicos |
Family Cites Families (42)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB845056A (en) | 1957-07-05 | 1960-08-17 | Egyt Gyogyszervegyeszeti Gyar | Improvements in or relating to tropane derivatives |
| DE1166787B (de) | 1960-07-09 | 1964-04-02 | Boehringer & Soehne Gmbh | Verfahren zur Herstellung von neuen Granatanol-(3ª‰)-estern und ihren Hydrohalogeniden |
| GB955535A (en) | 1962-10-22 | 1964-04-15 | Boehringer & Soehne Gmbh | New n-substituted norgranatanol-(3ª‰)-esters |
| DE2046659A1 (https=) | 1970-01-28 | 1972-03-23 | ||
| US3808263A (en) | 1970-05-12 | 1974-04-30 | Tanabe Seiyaku Co | 6,6-dimethyl-9-alkyl-9-azabicyclo(3.3.1)nonan-3-ols |
| US3673195A (en) | 1970-05-25 | 1972-06-27 | Tanabe Seiyaku Co | Derivatives of 6,6,9-tri-lower alkyl-9-azabicyclo(3.3.1) nonan-3{60 -or 3{62 -ol |
| US4353922A (en) | 1981-03-13 | 1982-10-12 | Syntex (U.S.A.) Inc. | Anticholinergic bronchodilators |
| US4570630A (en) | 1983-08-03 | 1986-02-18 | Miles Laboratories, Inc. | Medicament inhalation device |
| DE3682457D1 (de) | 1985-07-30 | 1991-12-19 | Glaxo Group Ltd | Geraet zur verabreichung von medikamenten an patienten. |
| DE3546218A1 (de) | 1985-12-27 | 1987-07-02 | Madaus & Co Dr | Azoniaspironortropanolester, verfahren zu deren herstellung und pharmazeutisches mittel |
| US5610163A (en) | 1989-09-16 | 1997-03-11 | Boehringer Ingelheim Gmbh | Esters of thienyl carboxylic acids and amino alcohols and their quaternization products |
| DE3931041C2 (de) | 1989-09-16 | 2000-04-06 | Boehringer Ingelheim Kg | Ester von Thienylcarbonsäuren mit Aminoalkoholen, ihre Quaternierungsprodukte, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel |
| US5770738A (en) | 1992-03-05 | 1998-06-23 | Boehringer Ingelheim Kg | Esters of bi- and tricyclic amino alcohols, their preparation and their use in pharmaceutical compositions |
| SK280911B6 (sk) | 1992-12-09 | 2000-09-12 | Boehringer Ingelheim Pharmaceuticals, Inc. | Farmaceutický prostriedok |
| DE4318455A1 (de) | 1993-06-03 | 1994-12-08 | Boehringer Ingelheim Kg | Kapselhalterung |
| CN1150890C (zh) | 1998-08-04 | 2004-05-26 | 杰格研究股份公司 | 药用气溶胶制剂 |
| DE19921693A1 (de) | 1999-05-12 | 2000-11-16 | Boehringer Ingelheim Pharma | Neuartige Arzneimittelkompositionen auf der Basis von anticholinergisch wirksamen Verbindungen und ß-Mimetika |
| ATE275391T1 (de) * | 2000-10-12 | 2004-09-15 | Boehringer Ingelheim Pharma | Neue tiotropium-haltige inhalationspulver |
| US6908928B2 (en) | 2000-10-12 | 2005-06-21 | Bi Pharma Kg. | Crystalline tiotropium bromide monohydrate, processes for the preparation thereof, and pharmaceutical compositions |
| CN100519558C (zh) | 2000-10-12 | 2009-07-29 | 贝林格尔英格海姆法玛两合公司 | 结晶单水合物、其制备方法及其在制备药物组合中的用途 |
| UA75375C2 (en) | 2000-10-12 | 2006-04-17 | Boehringer Ingelheim Pharma | Method for producing powdery preparations for inhaling |
| US20020111363A1 (en) | 2000-10-31 | 2002-08-15 | Karin Drechsel | Inhalable formulation of a solution containing a tiotropium salt |
| EP1837021A3 (de) | 2000-10-31 | 2008-03-19 | Boehringer Ingelheim Pharma GmbH & Co. KG | Inhalative Lösungsformulierung mit einem Tiotropiumsalz |
| DE10056104A1 (de) | 2000-11-13 | 2002-05-23 | Boehringer Ingelheim Pharma | Neue Arzneimittelkompositionen auf der Basis von Tiotropiumsalzen und Salzen des Salmeterols |
| US20020193392A1 (en) | 2000-11-13 | 2002-12-19 | Christel Schmelzer | Pharmaceutical compositions based on tiotropium salts of salts of salmeterol |
| DE10064816A1 (de) | 2000-12-22 | 2002-06-27 | Boehringer Ingelheim Pharma | Verfahren zur Herstellung eines Anticholinergikums |
| US6506900B1 (en) | 2001-01-31 | 2003-01-14 | Boehringer Ingelheim Pharma Ag | Process for preparing a scopine ester intermediate |
| DE10111843A1 (de) | 2001-03-13 | 2002-09-19 | Boehringer Ingelheim Pharma | Verbindungen zur Behandlung von inflammatorischen Erkrankungen |
| US20020193394A1 (en) | 2001-03-13 | 2002-12-19 | Bernd Disse | Compounds for treating inflammatory diseases |
| CZ302786B6 (cs) * | 2001-06-22 | 2011-11-09 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Krystalický bezvodý tiotropiumbromid, zpusob jeho výroby a jeho použití pro výrobu léciva pro lécbu asthmatu |
| US6608055B2 (en) * | 2001-06-22 | 2003-08-19 | Boehringer Ingelheim Pharma Kg | Crystalline anticholinergic, processes for preparing it and its use for preparing a pharmaceutical composition |
| GB0118373D0 (en) * | 2001-07-27 | 2001-09-19 | Glaxo Group Ltd | Novel therapeutic method |
| DE10200943A1 (de) | 2002-01-12 | 2003-07-24 | Boehringer Ingelheim Pharma | Verfahren zur Herstellung von Scopinestern |
| US20030229227A1 (en) | 2002-03-16 | 2003-12-11 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | New difurylglycolic acid esters, processes for the preparation thereof as well as the use thereof as pharmaceutical compositions |
| US7309707B2 (en) | 2002-03-20 | 2007-12-18 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Crystalline micronisate, process for the manufacture thereof and use thereof for the preparation of a medicament |
| DE10212264A1 (de) | 2002-03-20 | 2003-10-02 | Boehringer Ingelheim Pharma | Kristallines Mikronisat, Verfahren zu dessen Herstellung und dessen Verwendung zur Herstellung eines Arzneimittels |
| US7244415B2 (en) * | 2002-03-28 | 2007-07-17 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | HFA suspension formulations of an anhydrate |
| US7311894B2 (en) | 2002-03-28 | 2007-12-25 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | HFA suspension formulations containing an anticholinergic |
| DE10214264A1 (de) * | 2002-03-28 | 2003-10-16 | Boehringer Ingelheim Pharma | HFA-Suspensionsformulierungen eines Anhydrats |
| MXPA05006383A (es) * | 2002-12-16 | 2005-08-29 | Boehringer Ingelheim Pharma | Formulaciones de soluciones de hidrofluorocarburo que contienen tiotropio. |
| US7968717B2 (en) | 2003-11-03 | 2011-06-28 | Boehringer Ingelhein International Gmbh | Crystalline anhydrate with anticholinergic efficacy |
| DE102004041253A1 (de) | 2004-08-26 | 2006-03-02 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neues Verfahren zur Herstellung von Tiotropiumsalzen |
-
2006
- 2006-04-21 BR BRPI0609295-0A patent/BRPI0609295A2/pt not_active IP Right Cessation
- 2006-04-21 JP JP2008509408A patent/JP5227790B2/ja not_active Expired - Lifetime
- 2006-04-21 ES ES06754794T patent/ES2393794T3/es not_active Expired - Lifetime
- 2006-04-21 AU AU2006243238A patent/AU2006243238B2/en not_active Ceased
- 2006-04-21 DK DK06754794.3T patent/DK1881980T3/da active
- 2006-04-21 CN CN2006800142275A patent/CN101166738B/zh not_active Expired - Lifetime
- 2006-04-21 SI SI200631474T patent/SI1881980T1/sl unknown
- 2006-04-21 PL PL06754794T patent/PL1881980T3/pl unknown
- 2006-04-21 PT PT67547943T patent/PT1881980E/pt unknown
- 2006-04-21 RU RU2007144521/04A patent/RU2417224C2/ru active
- 2006-04-21 EP EP09157096A patent/EP2085396A3/en not_active Withdrawn
- 2006-04-21 CA CA002606549A patent/CA2606549A1/en not_active Abandoned
- 2006-04-21 EP EP06754794A patent/EP1881980B1/en not_active Expired - Lifetime
- 2006-04-21 NZ NZ563596A patent/NZ563596A/en not_active IP Right Cessation
- 2006-04-21 WO PCT/EP2006/061763 patent/WO2006117299A2/en not_active Ceased
- 2006-04-21 KR KR1020077028139A patent/KR20080012932A/ko not_active Ceased
- 2006-04-28 PE PE2006000456A patent/PE20061438A1/es not_active Application Discontinuation
- 2006-04-28 TW TW095115408A patent/TWI392674B/zh not_active IP Right Cessation
- 2006-04-28 AR ARP060101714A patent/AR053599A1/es unknown
- 2006-04-28 UY UY29506A patent/UY29506A1/es not_active Application Discontinuation
- 2006-05-01 US US11/381,076 patent/US7879871B2/en active Active
- 2006-12-07 MX MX2007013142A patent/MX2007013142A/es active IP Right Grant
-
2007
- 2007-09-19 ZA ZA200708048A patent/ZA200708048B/xx unknown
- 2007-10-31 IL IL187055A patent/IL187055A/en active IP Right Grant
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2008540366A5 (https=) | ||
| RU2007144521A (ru) | Новые кристаллические формы тиотропийбромида | |
| JP2008540367A5 (https=) | ||
| AU767349B2 (en) | Purine derivatives inhibitors of tyrosine protein kinase syk | |
| CN101412700B (zh) | 非布司他的晶型及其制备方法 | |
| BR112020014487A2 (pt) | composições farmacêuticas para tratamento de fi-brose cística | |
| KR20120120453A (ko) | Ｎ4-(2,2-다이플루오로-4ｈ-벤조〔1,4〕옥사진-3-온)-6-일〕-5-플루오로-ｎ2-〔3-(메틸아미노카보닐메틸렌옥시)페닐〕2,4-피리미딘다이아민의 지나포에이트 염 | |
| AU2004226824A1 (en) | Quinoline-2-one-derivatives for the treatment of airways diseases | |
| WO2011110852A1 (en) | Polymorphic forms of 6- [2- (4 -cyanophenyl) - 2h - pyrazol - 3 - yl] - 5 -methyl - 3 - oxo - 4 - (trifluoromethyl - phenyl) 3,4-dihydropyrazine-2-carboxylic acid ethylamide | |
| JP2000516932A (ja) | 新規のベンゾフラン―４―カルボキサミド | |
| BRPI0713590A2 (pt) | derivados de pirrol com atividade de modulador de receptor de crth2 | |
| JP2013540810A (ja) | １−｛（２Ｓ）−２−アミノ−４−［２，４−ビス（トリフルオロメチル）−５，８−ジヒドロピリド［３，４−ｄ］ピリミジン−７（６Ｈ）−イル］−４−オキソブチル｝−５，５−ジフルオロピペリジン−２−オン酒石酸塩の水和物 | |
| CN104797580A (zh) | 阿哌沙班的晶型或无定形及其制备工艺 | |
| TR201900735T4 (tr) | Yeni kaynaşık imidazobenzotiyazol bileşikleri. | |
| PT1651641E (pt) | Derivados de nicotinamida úteis como inibidores de pde4. | |
| CN102746276B (zh) | 一种艾普拉唑钠晶型及其制备方法 | |
| RU2012154006A (ru) | Кристаллическая форма гликопиррония хлорида | |
| CN103588457B (zh) | 低密度保温石膏板及其制备方法 | |
| JP2009508874A (ja) | イリノテカン塩酸塩の新規結晶形 | |
| CN109867674A (zh) | 一种取代的杂环稠合γ-咔啉的新盐及其制备方法和晶型 | |
| CN103204843B (zh) | 结晶型艾普拉唑钠乙醇化物及其制备方法 | |
| JP2010540440A5 (https=) | ||
| JPH05213934A (ja) | ピラゾール誘導体 | |
| RU2664538C2 (ru) | Тартратная соль [(s)-2-[метил-3-(2-оксо-пирролидин-1-ил)-бензолсульфониламино]-3-(4-метил-пиперазин-1-ил)-3-оксо-пропил]амида 5-хлор-тиофен-2-карбоновой кислоты | |
| US20090253798A1 (en) | Colchicine solid complex; methods of making; and methods of use thereof |